These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25546976)

  • 1. Polymorphism of angiotensin converting enzyme in hemodialysis patients--association with cardiovascular morbidity.
    Tošić JS; Đurić Ž; Popović J; Buzadžić I; Dimković S; Dimković N
    Med Pregl; 2014; 67(9-10):297-304. PubMed ID: 25546976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients].
    Fedor R; Kovács DÁ; Lőcsey L; Fagyas M; Asztalos L; Tóth A
    Orv Hetil; 2016 Jun; 157(24):938-45. PubMed ID: 27263433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.
    Ishimitsu T; Tsukada K; Ohta S; Inada H; Minami J; Ono H; Matsuoka H
    Am J Kidney Dis; 2004 Sep; 44(3):466-75. PubMed ID: 15332219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and predictive factors of lethality in hemodialysis: D/I polymorphism of the angiotensin I-converting enzyme and of the angiotensinogen M235T genes.
    Alves M; Souza e Silva NA; Salis LH; Pereira Bde B; Godoy PH; Nascimento EM; Oliveira JM
    Arq Bras Cardiol; 2014 Sep; 103(3):209-19. PubMed ID: 25076182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
    Sayed-Tabatabaei FA; Schut AF; Arias Vásquez A; Bertoli-Avella AM; Hofman A; Witteman JC; van Duijn CM
    J Med Genet; 2005 Jan; 42(1):26-30. PubMed ID: 15635071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme polymorphism in patients with terminal renal failure.
    Schmidt A; Kiener HP; Barnas U; Arias I; Illievich A; Auinger M; Graninger W; Kaider A; Mayer G
    J Am Soc Nephrol; 1996 Feb; 7(2):314-7. PubMed ID: 8785402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake?
    Heine GH; Ulrich C; Köhler H; Girndt M
    Am J Nephrol; 2004; 24(4):461-8. PubMed ID: 15331890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
    Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role of angiotensin-converting enzyme gene polymorphism in the failure of arteriovenous femoral shunts for hemodialysis?
    Isbir CS; Akgun S; Yilmaz H; Civelek A; Ak K; Tekeli A; Agachan B; Cobanoglu A
    Ann Vasc Surg; 2001 Jul; 15(4):443-6. PubMed ID: 11525534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients.
    Kato N; Tatara Y; Ohishi M; Takeya Y; Onishi M; Maekawa Y; Rakugi H
    Hypertens Res; 2011 Jun; 34(6):728-34. PubMed ID: 21412245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients.
    du Cheyron D; Fradin S; Ramakers M; Terzi N; Guillotin D; Bouchet B; Daubin C; Charbonneau P
    Crit Care Med; 2008 Dec; 36(12):3178-83. PubMed ID: 19020433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC.
    Oruç N; Lamb J; Whitcomb DJ; Sass DA
    Turk J Gastroenterol; 2008 Dec; 19(4):250-3. PubMed ID: 19119484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism.
    Molad Y; Gal E; Magal N; Sulkes J; Mukamel M; Weinberger A; Lalazari S; Shohat M
    Semin Arthritis Rheum; 2000 Oct; 30(2):132-7. PubMed ID: 11071585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the angiotensinogen M235T and the angiotensin-converting enzyme I/D polymorphisms on arterial hypertension and other cardiovascular risk factors].
    Pamies Andreu E; Palmero Palmero C; García Lozano R; Stiefel García-Junco P; Miranda Guisado ML; Martín Sanz V; Villar Ortiz J; Núñez Roldán A; Carneado de la Fuente J
    Med Clin (Barc); 1999 Jul; 113(5):164-8. PubMed ID: 10480138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients.
    Higashiuesato Y; Tana T; Tozawa M; Iseki C; Iseki K; Fukiyama K; Takishita S
    Clin Nephrol; 2002 Nov; 58(5):370-5. PubMed ID: 12425488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
    Zhou TB; Yin SS; Liang R
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.